AVEO Pharma (AVEO) Sees IPO Price of $13 - $15
Tweet Send to a FriendGet Alerts AVEO Hot Sheet
Up)
Trade AVEO Now!
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) has filed an amended registration statement with the SEC for an initial public offering of its common stock. The Company is offering 7,000,000 shares and expects the offering price to be between $13 - $15 per share. The Company plans to list on the NASDAQ Global Market under the symbol "AVEO".
The offering is being made through J.P. Morgan and Morgan Stanley.
AVEO is a biopharmaceutical company focused on discovering, developing and commercializing novel cancer therapeutics. Their product candidates are directed against important mechanisms, or targets, known or believed to be involved in cancer.
The offering is being made through J.P. Morgan and Morgan Stanley.
AVEO is a biopharmaceutical company focused on discovering, developing and commercializing novel cancer therapeutics. Their product candidates are directed against important mechanisms, or targets, known or believed to be involved in cancer.
You May Also Be Interested In
- Morgan Stanley Maintains Bullish Stance on Walter Energy (WLT)
- Gigamon (GIMO) Takes a Breather
- Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- AVEO
Create E-mail Alert Related Categories
IPOsRelated Entities
JPMorgan, Morgan Stanley
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
